Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Stryker Corp (NY:SYK)

376.83 -1.01 (-0.27%)
Official Closing Price Updated: 7:00 PM EDT, Sep 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Stryker Corp

< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
Stryker Corp (NYSE:SYK) Beats Q2 2025 Revenue and EPS Estimates but Shares Drop 4% in After-Hours Trading
Stryker Corp (NYSE:SYK) beat Q2 2025 revenue and EPS estimates but shares fell 4% post-earnings. Strong MedSurg and Orthopaedics growth offset by market caution. 
Via Chartmill
Stryker reports second quarter 2025 operating results
From Stryker Corporation
Via GlobeNewswire
Meta, Microsoft Power Wall Street To New Records Despite Inflation Jump: What's Moving Markets Thursday?
A post-earnings surge in Meta Platforms Inc. (NASDAQ:META) and Microsoft Corp. 
Via Benzinga
Topics Economy
If You Invested $100 In This Stock 20 Years Ago, You Would Have This Much Today
 
Via Benzinga
Earnings Scheduled For July 31, 2025
 
Via Benzinga
What Does the Market Think About Stryker?
 
Via Benzinga
A Look Into Stryker Inc's Price Over Earnings
 
Via Benzinga
Looking Into Stryker's Recent Short Interest
 
Via Benzinga
How Do Investors Really Feel About Stryker?
 
Via Benzinga
Stryker (SYK) To Report Earnings Tomorrow: Here Is What To Expect
Medical technology company Stryker (NYSE:SYK) will be reporting results this Thursday after market close. Here’s what you need to know. 
Via StockStory
Topics Artificial Intelligence
1 Mooning Stock on Our Watchlist and 2 We Question
The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals strong business execution, positive market sentiment, or significant... 
Via StockStory
Many Think Doctors Are Overpaid And That's Why Healthcare Is So Pricey, But One U.S. Surgeon Actually Ran The Numbers Against Global Peers
 
Via Benzinga
2 Unpopular Stocks That Should Get More Attention and 1 We Ignore
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other... 
Via StockStory
How Do Investors Really Feel About Stryker?
 
Via Benzinga
Here's How Much $1000 Invested In Stryker 20 Years Ago Would Be Worth Today
 
Via Benzinga
$100 Invested In This Stock 10 Years Ago Would Be Worth This Much Today
 
Via Benzinga
Rep. Thomas Kean Has Sold Up to $65K Worth Of Stryker Stock: Here's What You Should Know
 
Via Benzinga
The Analyst Verdict: Stryker In The Eyes Of 5 Experts
 
Via Benzinga
Here's How Much You Would Have Made Owning Stryker Stock In The Last 5 Years
 
Via Benzinga
Stryker to announce financial results for its second quarter of fiscal year 2025
From Stryker Corporation
Via GlobeNewswire
Stryker receives FDA clearance for Incompass Total Ankle System
From Stryker
Via Business Wire
Stryker (SYK): Buy, Sell, or Hold Post Q1 Earnings?
Since December 2024, Stryker has been in a holding pattern, posting a small return of 1.1% while floating around $376.76. 
Via StockStory
Topics Supply Chain
2 Safe-and-Steady Stocks to Research Further and 1 to Approach with Caution
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere. 
Via StockStory
$1000 Invested In This Stock 10 Years Ago Would Be Worth This Much Today
 
Via Benzinga
5 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off
Steady growth and dividend increases over decades can make investors remarkably wealthy. 
Via The Motley Fool
Topics Economy
5 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
Stryker Receives FDA Clearance For OptaBlate System Aimed At Low Back Pain Relief: Retail’s Yet To React
OptaBlate BVNA is used in a targeted minimally invasive procedure to relieve vertebrogenic low back pain. 
Via Stocktwits
Topics World Trade
Recent Filing Shows That Rep. Thomas Kean Bought Over $9K Worth of Amazon.com Stock
 
Via Benzinga
SYK Q1 Earnings Call: Stryker Delivers Revenue Beat, Cites International Growth and Tariff Headwinds
Medical technology company Stryker (NYSE:SYK) announced better-than-expected revenue in Q1 CY2025, with sales up 11.9% year on year to $5.87 billion. Its non-GAAP profit of $2.84 per share was 4% above... 
Via StockStory
Topics Economy
2 Large-Cap Stocks on Our Watchlist and 1 to Think Twice About
Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth... 
Via StockStory
< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.